Transcription of Risk Assessment - NHLBI, NIH
{{id}} {{{paragraph}}}
Example: stock market
Risk Assessment - NHLBI, NIH
Assessing Cardiovascular Risk Systematic Evidence Review From the Risk Assessment Work Group, 2013 ASSESSING CARDIOVASCULAR RISK: SYSTEMATIC EVIDENCE REVIEW FROM THE RISK Assessment WORK GROUP, 2013 i Contents v Risk Assessment Work Group .. vi Section 1: Background and Description of the NHLBI Cardiovascular Risk Reduction Project .. 1 Background .. 1 Overview of the Evidence-Based Methodology .. 2 i. System for Grading the Body of Evidence .. 3 ii. Peer-Review Process .. 4 iii. Critical Question-Based Approach .. 4 Charge to the Risk Assessment Work Group .. 4 Considerations in Developing the Approach to Risk Assessment .. 5 Methods for Modeling Risk and Developing Algorithms .. 6 Development of ASCVD Risk Equations .. 10 i. Internal Validation .. 16 ii. External Validation .. 17 iii. Limitations .. 21 Implications for Risk Assessment .. 21 Section 2. Critical 44 A. CQ1 .. 44 i. Selection of the I/E Criteria.
risk assessment, cholesterol, and obesity. The new guidelines—published in November 2013 by the AHA, ACC, and TOS, and endorsed by other professional societies—provide a valuable updated roadmap to help
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: